ATM and cancer: The central DNA damage signaling proteins DNA-dependent protein kinase (DNA-PKcs), ataxia telangiectasia mutated (ATM), and ataxia telangiectasia and rad-3-related (ATR) kinases have become promising targets in cancer therapy7,8.